Closed · CDC-RFA-PS22-2208 · CFDA 93.488 · Discretionary
Strengthening Syringe Services Programs
Federal grant opportunity posted by Centers for Disease Control - NCHHSTP, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- May 2, 2022
- Close date
- 2
- Expected awards
The verdict
Strengthening Syringe Services Programs is a closed discretionary listing from Centers for Disease Control - NCHHSTP that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 93.488
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Strengthening Syringe Services Programs - is cataloged under number CDC-RFA-PS22-2208 and tied to CFDA assistance listing 93.488, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on March 1, 2022 and last updated on March 2, 2022. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. The agency has projected $50.0 million in total estimated funding for this announcement. It expects to issue 2 awards. If the agency funds the expected 2 awards from the $50.0 million estimated pool, the average award works out to roughly $25.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on May 2, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
May 2, 2022
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
March 1, 2022
Est. Total Funding
$50,000,000
Expected Awards
2
Instrument
Cooperative Agreement
Description
This NOFO aims to increase access to harm reduction services for people who currently inject or have a history of injecting drugs (PWID) and reduce incidence of infectious diseases and complications of injection drug use through two components. Component 1 will expand a national network of syringe services programs (SSPs) to facilitate communication and networking among SSPs, other harm reduction programs, and trusted national organizations with a demonstrated portfolio in improving the health of persons who use drugs (PWUD). This component also improves data about SSPs by surveying SSPs to document capacity, needs, and service gaps. Component 2 will increase support and resources to SSPs for implementation of distribution of sterile injection supplies and disposal of used injection supplies; testing, treatment, and prevention of infectious diseases and infectious complications from injection drug use; and mitigation of other harms due to drug use. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include: improved collaboration, communication, and data about SSPs nationwide; increased access to harm reduction services; decreased unsafe injection practices; decreased new infections of HCV, HBV, HAV, HIV, endocarditis, and other infections; decreased overdose rates and mortality; increased capacity for responding to outbreaks of infections associated with injection drug use; and increased services available through SSPs in the United States.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Aleta Christensen yno7@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |